• Vol. 27 No. 5, 693–697
  • 15 September 1998

Fallopian Tube Carcinoma—A Review



Download PDF


Although a common site of metastases, primary fallopian tube carcinoma comprises only 0.3% of all gynaecological malignancies. Presenting symptoms are variable and non-specific, with preoperative diagnosis rarely entertained. The FIGO system assigns nearly two-thirds of patients to stage I or II and is based on surgical staging criteria similar to those for ovarian cancer.

Likewise, management is based on that for ovarian cancer-radical debulking followed by platinum-based combination chemotherapy. Five-year survival for patients with disease confined to the tube at diagnosis (stage I) is only about 60% and only 10% of patients with advanced disease will be cured.

Fallopian tube cancer is the least common of gynaecological malignancies. It was first described by Renaud in 1847.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.